Treace Medical Concepts, Inc TMCI
📋 Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2021-04-23 |
| Shares Out. | 64,870,000 |
| Website | treace.com/ ↗ |
| Phone | 19043735940 |
| Employees | 450 |
| Revenue | $47.2M |
| Gross Profit | $37.4M |
| Net Income | -$18.0M |
| Free Cash Flow | -$26.0M |
| Total Assets | $184.1M |
| Total Liabilities | $106.9M |
| Equity | $77.2M |
About Treace Medical Concepts, Inc
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The company operates and manages its business as a single segment: designing, manufacturing, and marketing medical devices for surgeons, ambulatory surgery centers, and hospitals related to the surgical management of bunion and related midfoot deformities.
Treace Medical Concepts, Inc is a publicly traded company under the ticker symbol TMCI on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
10 analysts (2026-07-01)